KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

BioNTech SE (BNTX) Tax Provisions: 2017-2024

Historic Tax Provisions for BioNTech SE (BNTX) over the last 8 years, with Dec 2024 value amounting to -$13.3 million.

  • BioNTech SE's Tax Provisions fell 244.27% to -$62.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$57.6 million, marking a year-over-year increase of 64.35%. This contributed to the annual value of -$13.3 million for FY2024, which is 104.81% down from last year.
  • According to the latest figures from FY2024, BioNTech SE's Tax Provisions is -$13.3 million, which was down 104.81% from $275.2 million recorded in FY2023.
  • BioNTech SE's Tax Provisions' 5-year high stood at $5.4 billion during FY2021, with a 5-year trough of -$192.0 million in FY2020.
  • For the 3-year period, BioNTech SE's Tax Provisions averaged around $1.3 billion, with its median value being $275.2 million (2023).
  • Its Tax Provisions has fluctuated over the past 5 years, first tumbled by 86,610.99% in 2020, then spiked by 2,933.07% in 2021.
  • Over the past 5 years, BioNTech SE's Tax Provisions (Yearly) stood at -$192.0 million in 2020, then soared by 2,933.07% to $5.4 billion in 2021, then slumped by 33.97% to $3.6 billion in 2022, then tumbled by 92.34% to $275.2 million in 2023, then plummeted by 104.81% to -$13.3 million in 2024.